glp 1 hub podcast GLP-1 Hub: Support, Community, and Weight Loss Fighting for GLP-1 Access: Advocacy

In the Phase 2 clinical trial published in the New England Journal of Medicine (2023), participants receiving retatrutide achieved mean weight reductions of up to approximately 24% over 48 weeks

For years intravenous glutathione injections have been clinically recognized for their therapeutic value in treating acute poisoning and chronic liver disease

236 They also promote hepatocyte autophagy, facilitating the clearance of damaged mitochondria and reducing ROS production, alleviating inflammatory and lipid metabolism disorders

Wellness injections exist at a lower price tier

Both versions target the same mechanism, and both contain the same three strains